Oestrogen pessaries, as outlined in the British National Formulary (BNF), are a commonly prescribed treatment for managing menopausal symptoms and urogenital atrophy in women. These pessaries provide a localized form of oestrogen therapy, delivering the hormone directly to the vaginal tissues, which helps relieve symptoms such as dryness, irritation, burning, and discomfort during sexual activity. Unlike systemic hormone replacement therapy, oestrogen pessaries work locally, reducing the risk of systemic side effects while improving the health and function of vaginal and urethral tissues. Their use is recommended for women experiencing moderate to severe urogenital symptoms, and they are an important aspect of women’s health care management as described in the BNF guidelines.
What is an Oestrogen Pessary?
An oestrogen pessary is a small, solid, or semi-solid medicated device inserted into the vagina to deliver low-dose oestrogen locally. The pessary dissolves gradually, releasing the hormone directly to the vaginal walls. This localized administration is particularly useful for treating symptoms of vulvovaginal atrophy caused by reduced oestrogen levels during and after menopause. According to the BNF, oestrogen pessaries can be used both short-term and long-term depending on symptom severity, response to treatment, and ongoing medical assessment.
Forms and Dosage
Oestrogen pessaries are available in different formulations and strengths. The BNF provides guidance on appropriate dosages for initial treatment and maintenance therapy. Typically, the treatment may begin with a higher dose to alleviate symptoms and then shift to a lower maintenance dose once the desired effect is achieved. Pessaries are usually inserted daily for the first two weeks, followed by a reduced frequency, such as twice weekly, based on individual response and clinical guidance.
Indications for Use
The BNF highlights that oestrogen pessaries are primarily indicated for women with vulvovaginal atrophy or urogenital symptoms associated with menopause. These symptoms can include vaginal dryness, irritation, itching, dyspareunia (pain during sexual activity), recurrent urinary tract infections, and minor urinary incontinence. Oestrogen pessaries help restore the thickness and elasticity of the vaginal lining, increase lubrication, and improve local blood flow, which alleviates these symptoms and enhances overall vaginal health.
Additional Clinical Uses
- Prevention and management of recurrent urinary tract infections in postmenopausal women
- Support during recovery from gynecological procedures that affect vaginal tissues
- Adjunctive therapy for women using systemic hormone replacement therapy who require additional local relief
Benefits of Oestrogen Pessaries
Using an oestrogen pessary offers several advantages over systemic hormone therapies, particularly in terms of safety and targeted symptom relief. Because the hormone is delivered locally, systemic absorption is minimal, reducing the risk of complications such as blood clots, cardiovascular issues, or breast tissue effects. Pessaries can effectively restore vaginal tissue integrity, relieve discomfort, and improve sexual function without exposing the entire body to elevated oestrogen levels.
Improved Quality of Life
Women who use oestrogen pessaries often report improved comfort during daily activities and sexual intimacy. Relief from dryness and irritation can significantly enhance quality of life, especially for women who experience severe discomfort. Consistent use according to BNF guidance ensures gradual improvement in tissue health, minimizing the likelihood of recurring symptoms and maintaining vaginal well-being over time.
Administration and Use
Correct administration of an oestrogen pessary is essential for achieving optimal results. The BNF emphasizes hygiene and proper insertion techniques. Pessaries are typically inserted into the vagina using clean hands, sometimes with the aid of an applicator, and positioned high in the vaginal canal for maximal absorption. Regular washing and careful handling prevent infections and maintain effectiveness. Women are often advised to avoid sexual intercourse immediately after insertion for a few hours to allow for proper absorption.
Monitoring and Follow-Up
The BNF recommends that women using oestrogen pessaries undergo periodic follow-up to monitor symptom relief, evaluate side effects, and adjust dosage if necessary. While local side effects are usually mild, such as temporary irritation or discharge, regular medical review ensures safe and effective long-term use. Healthcare professionals may also assess overall hormone therapy needs and consider whether adjunctive systemic therapy is appropriate.
Safety and Precautions
Oestrogen pessaries are generally safe when used as directed, but certain precautions are advised. Women with a history of oestrogen-sensitive cancers, unexplained vaginal bleeding, liver disease, or blood clotting disorders should consult their healthcare provider before using pessaries. The BNF provides guidance on contraindications, drug interactions, and monitoring protocols to ensure patient safety. Women should also report any unusual symptoms, such as severe pain, persistent bleeding, or signs of infection, promptly to their healthcare provider.
Potential Side Effects
- Vaginal irritation or burning
- Increased vaginal discharge
- Spotting or minor bleeding
- Rare systemic effects if absorption is higher than expected
Overall, these side effects are usually mild and resolve with dose adjustment or discontinuation. Following BNF recommendations minimizes risks and ensures safe, effective treatment for menopausal or postmenopausal symptoms.
Comparisons to Other Oestrogen Therapies
Unlike systemic hormone replacement therapy, which circulates oestrogen throughout the body, oestrogen pessaries act locally and provide targeted relief. Other local options, such as oestrogen creams or vaginal rings, offer similar benefits, but pessaries have the advantage of sustained release and convenient dosing schedules. The choice between these options depends on patient preference, symptom severity, and guidance from healthcare professionals, as detailed in the BNF.
Advantages Over Creams and Rings
- Simple administration without daily mess
- Longer-lasting effect due to slow dissolution
- Reduced risk of accidental systemic absorption
- Discrete and convenient for regular use
Oestrogen pessaries, as described in the BNF, are an effective and safe treatment option for women experiencing menopausal or postmenopausal urogenital symptoms. By delivering local hormone therapy directly to vaginal tissues, pessaries provide targeted symptom relief, improve tissue health, and enhance quality of life. Their use, guided by BNF recommendations, ensures correct dosing, safe administration, and effective monitoring of side effects. For women experiencing discomfort related to oestrogen deficiency, pessaries offer a practical and well-tolerated solution that supports vaginal and urinary health while minimizing systemic risks. Regular consultation with healthcare professionals is essential to maximize benefits, tailor treatment plans, and ensure ongoing safety, making oestrogen pessaries a cornerstone of women’s health management in postmenopausal care.